Apervita, a US-based healthcare performance analytics platform developer backed by conglomerate General Electric, collected $22m on Tuesday in a round featuring financial services provider Wintrust.
The round also included venture capital and private equity firm Baird Capital, real estate-focused investment office Levy Family Partners, Pritzker Group Venture Capital and Illinois Venture.
Founded in 2012, Apervita has built a cloud-hosted analytics platform for measuring the clinical and financial performance of healthcare providers against peer-to-peer, industry and customised benchmarks.
Apervita supports contractual evaluations of healthcare provision. For example, the US medical practice accreditation board The Joint Commission uses the technology to digitally screen regulatory applications.
The company will use the capital to invest in its core technology and take forward its expansion plans in consultation with its client base. Apervita previously acquired medical payments management tools provider Qcentive in August 2019.
General Electric’s corporate venturing unit, GE Ventures, co-led Apervita’s $18m series A round with Baird Capital in 2015, investing alongside Pritzker, Math Ventures and undisclosed existing investors.
The company previously obtained $1.4m of equity and debt from unnamed investors in 2013, according to a filing.